The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer

Cellular and Molecular Biology Letters

Volumn 18, Issue 4, 2013, Pages 595-611

  Wazir, Umar ^a,b   Ahmed, Mai Hassan ^c,d   Bridger, Joanna M ^c   Harvey, Amanda ^d   Jiang, Wen G ^e   Sharma, Anup K ^a   Mokbel, Kefah ^a,b  

^a Princess Grace Hospital   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c Chester Beatty Laboratories   (United Kingdom)

^d BRUNEL UNIVERSITY   (United Kingdom)

^e CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Ageing; Breast cancer; Cell cycle; Cell senescence; Chromosomal instability; DNA repair; Lamin A C; Lamin B; Lamin B receptor; qPCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; LAMIN; LAMIN A; LAMIN B RECEPTOR; LAMIN B1; LAMIN C; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER TISSUE; COLLOID CARCINOMA; CONTROLLED STUDY; DETERIORATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EARLY CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MULTIMODALITY CANCER THERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTTINGHAM PROGNOSTIC INDEX; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST; BREAST NEOPLASMS; CELL CYCLE; CHROMOSOMAL INSTABILITY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMIN TYPE A; LAMIN TYPE B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER;

EID: 84891346537     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-013-0109-9     Document Type: Article

References (48)

1. Bridger, J. M., Foeger, N., Kill, I. R. and Herrmann, H. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J. 274 (2007) 1354-1361.
2. Guelen, L., Pagie, L., Brasset, E., Meuleman, W., Faza, M. B., Talhout, W., Eussen, B. H., de Klein, A., Wessels, L., de Laat, W. and van Steensel, B. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature453 (2008) 948-951. DOI: 10. 1038/nature06947.
3. Malhas, A., Lee, C. F., Sanders, R., Saunders, N. J. and Vaux, D. J. Defects in lamin B1 expression or processing affect interphase chromosome position and gene expression. J. Cell Biol. 176 (2007) 593-603. DOI: 10. 1083/jcb. 200607054.
4. Bridger, J. M., Kill, I. R., O'Farrell, M. and Hutchison, C. J. Internal lamin structures within G1 nuclei of human dermal fibroblasts. J. Cell Sci. 104 (1993) 297-306.
5. Goldman, A. E., Moir, R. D., Montag-Lowy, M., Stewart, M. and Goldman, R. D. Pathway of incorporation of microinjected lamin A into the nuclear envelope. J. Cell Biol. 119 (1992) 725-735.
6. Solovei, I., Wang, A. S., Thanisch, K., Schmidt, C. S., Krebs, S., Zwerger, M., Cohen, T. V., Devys, D., Foisner, R., Peichl, L., Herrmann, H., Blum, H., Engelkamp, D., Stewart, C. L., Leonhardt, H. and Joffe, B. LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell152 (2013) 584-598. DOI: 10. 1016/j. cell. 2013. 01. 009.
7. Zhang, H., Kieckhaefer, J. E. and Cao, K. Mouse models of laminopathies. Aging Cell12 (2013) 2-10. DOI: 10. 1111/acel. 12021.
8. Worman, H. J., Ostlund, C. and Wang, Y. Diseases of the nuclear envelope. Cold Spring Harb. Perspect. Biol. 2 (2010) a000760. DOI: 10. 1101/cshperspect. a000760.
9. Chi, Y. H., Chen, Z. J. and Jeang, K. T. The nuclear envelopathies and human diseases. J. Biomed. Sci. 16 (2009) 96. DOI: 10. 1186/1423-0127-16-96.
10. Kong, L., Schafer, G., Bu, H., Zhang, Y. and Klocker, H. Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. Carcinogenesis33 (2012) 751-759. DOI: 10. 1093/carcin/bgs022.
11. Helfand, B. T., Wang, Y., Pfleghaar, K., Shimi, T., Taimen, P. and Shumaker, D. K. Chromosomal regions associated with prostate cancer risk localize to lamin B-deficient microdomains and exhibit reduced gene transcription. J. Pathol. 226 (2012) 735-745. DOI: 10. 1002/path. 3033.
12. Luk, J. M. and Liu, A. M. Proteomics of hepatocellular carcinoma in Chinese patients. OMICS15 (2011) 261-266. DOI: 10. 1089/omi. 2010. 0099.
13. Al Sarakbi, W., Sasi, W., Jiang, W. G., Roberts, T., Newbold, R. F. and Mokbel, K. The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer9 (2009) 290. DOI: 10. 1186/1471-2407-9-290.
14. Elkak, A., Mokbel, R., Wilson, C., Jiang, W. G., Newbold, R. F. and Mokbel, K. hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer. Anticancer Res. 26 (2006) 4901-4904.
15. Wazir, U., Jiang, W. G., Sharma, A. K. and Mokbel, K. The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters. Anticancer Res. 32 (2012) 671-674.
16. Jiang, W. G., Watkins, G., Lane, J., Cunnick, G. H., Douglas-Jones, A., Mokbel, K. and Mansel, R. E. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin. Cancer Res. 9 (2003) 6432-6440.
17. Lin, F. and Worman, H. J. Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J. Biol. Chem. 268 (1993) 16321-16326.
18. Bonne, G., Di Barletta, M. R., Varnous, S., Becane, H. M., Hammouda, E. H., Merlini, L., Muntoni, F., Greenberg, C. R., Gary, F., Urtizberea, J. A., Duboc, D., Fardeau, M., Toniolo, D. and Schwartz, K. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 21 (1999) 285-288. DOI: 10. 1038/6799.
19. Maraldi, N. M., Capanni, C., Cenni, V., Fini, M. and Lattanzi, G. Laminopathies and lamin-associated signaling pathways. J. Cell Biochem. 112 (2011) 979-992. DOI: 10. 1002/jcb. 22992.
20. Cenni, V., Capanni, C., Columbaro, M., Ortolani, M., D'Apice, M. R., Novelli, G., Fini, M., Marmiroli, S., Scarano, E., Maraldi, N. M., Squarzoni, S., Prencipe, S. and Lattanzi, G. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. Eur. J. Histochem. 55 (2011) e36. DOI: 10. 4081/ejh. 2011. e36.
21. Cao, K., Graziotto, J. J., Blair, C. D., Mazzulli, J. R., Erdos, M. R., Krainc, D. and Collins, F. S. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 3 (2011) 89ra58. DOI: 10. 1126/scitranslmed. 3002346.
22. Ramos, F. J., Chen, S. C., Garelick, M. G., Dai, D. F., Liao, C. Y., Schreiber, K. H., MacKay, V. L., An, E. H., Strong, R., Ladiges, W. C., Rabinovitch, P. S., Kaeberlein, M. and Kennedy, B. K. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci. Transl. Med. 4 (2012) 144ra103. DOI: 10. 1126/scitranslmed. 3003802.
23. Wydner, K. L., McNeil, J. A., Lin, F., Worman, H. J. and Lawrence, J. B. Chromosomal assignment of human nuclear envelope protein genes LMNA, LMNB1, and LBR by fluorescence in situ hybridization. Genomics32 (1996) 474-478. DOI: 10. 1006/geno. 1996. 0146.
24. Tsai, M. Y., Wang, S., Heidinger, J. M., Shumaker, D. K., Adam, S. A., Goldman, R. D. and Zheng, Y. A mitotic lamin B matrix induced by RanGTP required for spindle assembly. Science311 (2006) 1887-1893. DOI: 10. 1126/science. 1122771.
25. Worman, H. J. and Bonne, G. "laminopathies": a wide spectrum of human diseases. Exp. Cell Res. 313 (2007) 2121-2133. DOI: 10. 1016/j. yexcr. 2007. 03. 028.
26. Young, S. G., Jung, H. J., Coffinier, C. and Fong, L. G. Understanding the roles of nuclear A- and B-type lamins in brain development. J. Biol. Chem. 287 (2012) 16103-16110. DOI: 10. 1074/jbc. R112. 354407.
27. Coffeen, C. M., McKenna, C. E., Koeppen, A. H., Plaster, N. M., Maragakis, N., Mihalopoulos, J., Schwankhaus, J. D., Flanigan, K. M., Gregg, R. G., Ptacek, L. J. and Fu, Y. H. Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. Hum. Mol. Genet. 9 (2000) 787-793.
28. Hegele, R. A., Cao, H., Liu, D. M., Costain, G. A., Charlton-Menys, V., Rodger, N. W. and Durrington, P. N. Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am. J. Hum. Genet. 79 (2006) 383-389. DOI: 10. 1086/505885.
29. Olins, A. L., Rhodes, G., Welch, D. B., Zwerger, M. and Olins, D. E. Lamin B receptor: multi-tasking at the nuclear envelope. Nucleus1 (2010) 53-70. DOI: 10. 4161/nucl. 1. 1. 10515.
30. Hoffmann, K., Sperling, K., Olins, A. L. and Olins, D. E. The granulocyte nucleus and lamin B receptor: avoiding the ovoid. Chromosoma116 (2007) 227-235. DOI: 10. 1007/s00412-007-0094-8.
31. Waterham, H. R., Koster, J., Mooyer, P., Noort Gv, G., Kelley, R. I. and Wilcox, W. R. Autosomal recessive hem/greenberg skeletal dysplasia is caused by 3betahydroxysterol delta 14-reductase deficiency due to mutations in the lamin b receptor gene. Am. J. Hum. Genet. 72 (2003) 1013-1017.
32. Butin-Israeli, V., Adam, S. A., Goldman, A. E. and Goldman, R. D. Nuclear lamin functions and disease. Trends Genet. 28 (2012) 464-471. DOI: 10. 1016/j. tig. 2012. 06. 001.
33. Fischer, A. H., Taysavang, P., Weber, C. J. and Wilson, K. L. Nuclear envelope organization in papillary thyroid carcinoma. Histol. Histopathol. 16 (2001) 1-14.
34. Foster, C. R., Robson, J. L., Simon, W. J., Twigg, J., Cruikshank, D., Wilson, R. G. and Hutchison, C. J. The role of lamin A in cytoskeleton organization in colorectal cancer cells: a proteomic investigation. Nucleus2 (2011) 434-443. DOI: 10. 4161/nucl. 2. 5. 17775.
35. Willis, N. D., Cox, T. R., Rahman-Casans, S. F., Smits, K., Przyborski, S. A., van den Brandt, P., van Engeland, M., Weijenberg, M., Wilson, R. G., de Bruine, A. and Hutchison, C. J. Lamin A/C is a risk biomarker in colorectal cancer. PLoS ONE3 (2008) e2988. DOI: 10. 1371/journal. pone. 0002988.
36. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G. and Snyder, M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U S A104 (2007) 17494-17499. DOI: 10. 1073/pnas. 0708572104.
37. Kaufmann, S. H., Mabry, M., Jasti, R. and Shaper, J. H. Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines. Cancer Res. 51 (1991) 581-586.
38. Broers, J. L., Raymond, Y., Rot, M. K., Kuijpers, H., Wagenaar, S. S. and Ramaekers, F. C. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am. J. Pathol. 143 (1993) 211-220.
39. Moss, S. F., Krivosheyev, V., de Souza, A., Chin, K., Gaetz, H. P., Chaudhary, N., Worman, H. J. and Holt, P. R. Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut45 (1999) 723-729.
40. Venables, R. S., McLean, S., Luny, D., Moteleb, E., Morley, S., Quinlan, R. A., Lane, E. B. and Hutchison, C. J. Expression of individual lamins in basal cell carcinomas of the skin. Br. J. Cancer84 (2001) 512-519. DOI: 10. 1054/bjoc. 2000. 1632.
41. Capo-chichi, C. D., Cai, K. Q., Simpkins, F., Ganjei-Azar, P., Godwin, A. K. and Xu, X. X. Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med. 9 (2011) 28. DOI: 10. 1186/1741-7015-9-28.
42. Wu, Z., Wu, L., Weng, D., Xu, D., Geng, J. and Zhao, F. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J. Exp. Clin. Cancer Res. 28 (2009) 8. DOI: 10. 1186/1756-9966-28-8.
43. Agrelo, R., Setien, F., Espada, J., Artiga, M. J., Rodriguez, M., Perez-Rosado, A., Sanchez-Aguilera, A., Fraga, M. F., Piris, M. A. and Esteller, M. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J. Clin. Oncol. 23 (2005) 3940-3947. DOI: 10. 1200/JCO. 2005. 11. 650.
44. Wong, K. F. and Luk, J. M. Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinoma. Methods Mol. Biol. 909 (2012) 295-310. DOI: 10. 1007/978-1-61779-959-4_19.
45. Sun, S., Xu, M. Z., Poon, R. T., Day, P. J. and Luk, J. M. Circulating lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J. Proteome Res. 9 (2010) 70-78. DOI: 10. 1021/pr9002118.
46. Coradeghini, R., Barboro, P., Rubagotti, A., Boccardo, F., Parodi, S., Carmignani, G., D'Arrigo, C., Patrone, E. and Balbi, C. Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol. Rep. 15 (2006) 609-613.
47. Wazir, U., Newbold, R. F., Jiang, W. G., Sharma, A. K. and Mokbel, K. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncol. Rep. 29 (2013) 1969-1974. DOI: 10. 3892/or. 2013. 2346.
48. Wander, S. A., Zhao, D., Besser, A. H., Hong, F., Wei, J., Ince, T. A., Milikowski, C., Bishopric, N. H., Minn, A. J., Creighton, C. J. and Slingerland, J. M. PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy. Breast Cancer Res. Treat. (2013) 369-381. DOI: 10. 1007/s10549-012-2389-6.